IOL Chemicals and Pharmaceuticals profitability ratios
Per cent unless marked ×
| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
Returns | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |||||
|---|---|---|---|---|---|---|
| 7.9% | 7.9% | 6.1% | 8.6% | 9.6% | ||
| 5.5% | 5.5% | 4.4% | 6.3% | 7.0% | ||
| 10.3% | 10.3% | 7.5% | 10.3% | 11.9% | ||
| 10.2% | 7.6% | 5.5% | 7.6% | 8.4% | ||
Margins | ||||||
| 13.2% | 11.6% | 9.7% | 10.8% | 10.2% | ||
| 8.1% | 8.1% | 6.3% | 7.9% | 8.1% | ||
| — | 24.4% | 69.7% | 14.0% | — | ||
| 9.9% | 7.9% | 6.6% | 8.5% | 8.5% | ||
| 7.4% | 5.9% | 4.9% | 6.3% | 6.3% | ||
| 1.8% | 1.8% | −1.7% | 0.8% | −4.0% | ||
Additional | ||||||
| 25.4% | 25.3% | 26.7% | 26.0% | 26.2% | ||
| — | 21.3% | 23.2% | 21.8% | 16.9% | ||
| 7.9% | 6.2% | 4.7% | 6.7% | 8.0% | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.